IGI Laboratories, Inc. (IG) Appoints Dr. Kenneth Miller as Senior Vice President – R&D
Yesterday, New Jersey-based generic topical pharmaceutical company IGI Laboratories announced that it has appointed Dr. Kenneth Miller as its Senior Vice President of R&D, effective December 17, 2012. Jason Grenfell-Gardner, IGI’s President and CEO, remarked, “Dr. Miller’s appointment brings significant practical experience in generic topical pharmaceuticals and leadership that will allow us to accelerate the growth of our ANDA pipeline. This pipeline is the key to growing IGI’s generic business, and we’re excited to have Dr. Miller leading our R&D team.” Dr. Miller has an extensive career with over 20 years of topical and transdermal experience in branded and generic…